Skip to main content
IEX
NYSE Technology

IDEX Corporation Reports Strong Q1 2026 Results with Double-Digit EPS Growth and Robust Sales

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Industrial Machinery Stocks · Industrial
Sentiment info
Positive
Importance info
8
Price
$217.34
Mkt Cap
$16.127B
52W Low
$157.25
52W High
$223.845
52W Position info
38% above low
Off High info
2.9% below high
Rel. Volume info
1.7× avg
Market data snapshot near publication time

IEX sits 38% above its 52-week low of $157.25.

Summary

IDEX Corporation reported strong first-quarter 2026 financial results, with significant increases in net sales and diluted EPS, driven by organic growth and strong performance in its Health & Science Technologies segment.


Key Events · Earnings and Guidance · IEX

  • Strong Q1 2026 Financial Performance

    Net sales increased 9% to $886.9 million (5% organic growth) compared to Q1 2025, with operating income rising 21% to $172.4 million.

  • Significant EPS Growth

    Reported diluted EPS attributable to IDEX grew 28% to $1.61, and adjusted diluted EPS increased 14% to $2.00, both compared to the prior year period.

  • Health & Science Technologies Segment Leads Growth

    The HST segment's organic sales increased 11%, primarily due to AI-driven demand in data center power and semiconductor markets, contributing significantly to overall sales growth.

  • Continued Share Repurchase Program

    The company repurchased 0.4 million shares for $75.6 million during Q1 2026, with $849.7 million remaining under authorization, demonstrating ongoing capital return to shareholders.


Analysis · IEX · Technology

IDEX Corporation's Q1 2026 results demonstrate robust financial performance, building on the preliminary announcement made in a concurrent 8-K filing. The company achieved significant year-over-year growth in both net sales and earnings per share, driven by strong organic sales and favorable market conditions, particularly within its Health & Science Technologies (HST) segment due to AI-driven demand. The continued share repurchase activity underscores management's commitment to returning capital to shareholders, supported by a healthy liquidity position and compliance with debt covenants. While operating cash flow saw a slight decrease, overall financial health remains strong, positioning the company well for future growth.

How filings like this one have moved

In the 30 days to Nov 17, 2026, 48.3% of the 2133 measured filings Wiseek scored 8 moved their stock by 5% or more by the next session's close. The median move was -0.28%. These are measured outcomes after filings of this importance, not a forecast for this one.

Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset

At the time of this filing, IEX was trading at $217.34 on NYSE in the Technology sector, with a market capitalization of approximately $16.1B. The 52-week trading range was $157.25 to $223.85. This filing was assessed with positive market sentiment and an importance score of 8 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

IEX - Latest Insights

IEX
Oct 28, 2026, 7:00 AM EDT
Source: BusinessWire
Importance Score:
8
Price at Filing: $233.48
Real-time Price: $233.26 info
Change: -$0.220 (-0.09%) info
Market Cap: $17.124B info
IEX
Jul 29, 2026, 4:35 PM EDT
Filing Type: 10-Q
Importance Score:
7
Price at Filing: $229.52
Real-time Price: $233.26 info
Change: +$3.74 (+2%) info
Market Cap: $17.124B info
IEX
Jul 29, 2026, 8:25 AM EDT
Source: dpa-AFX
Importance Score:
8
Price at Filing: $232.55
Real-time Price: $233.26 info
Change: +$0.710 (+0.31%) info
Market Cap: $17.124B info
IEX
Jul 29, 2026, 7:01 AM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $232.55
Real-time Price: $233.26 info
Change: +$0.710 (+0.31%) info
Market Cap: $17.124B info
IEX
Apr 29, 2026, 7:01 AM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $215.06
Real-time Price: $233.26 info
Change: +$18.20 (+8%) info
Market Cap: $17.124B info